loader2
Partner With Us NRI

Narayana Hrudayalaya Ltd share Price Today

Company details

1,211.35
1,261.00
748.90
1,444.90
6M Return 14.81%
1Y Return 63.49%
Mkt Cap.(Cr) 25,390.83
Volume 174,736
Div Yield 0.20%
OI
-
OI Chg %
-
Volume 174,736

Open Free Trading Account Online with ICICIDIRECT

Incur '0' Brokerage upto ₹500
Steady quarter amid seasonality; focus on new capex
About The Stock

    Narayana Hrudayalaya operates a chain of multispecialty, tertiary & primary healthcare facilities that initially focused on cardiac & renal but expanded to cancer, neurology, neurosurgery, orthopaedics and gastroenterology facilities.

    • NHL’s network comprises 21 hospitals (including two managed hospitals), four heart centres, 18 primary care facilities (including clinics and information centres) and a multi-speciality hospital in Cayman Islands)
    • Revenue mix Q3FY23 – India: ₹ 928.3 crore; (Bengaluru:35%, Southern Peripheral: 6%, Kolkata:26%, Eastern Peripheral: 10%, Western: 5%, Northern: 18%); Cayman Islands: US$ 28.2 million
Q3FY23 Results

    Steady performance across segments with margins beat.

    • Revenues de-grew 1.2% QoQ to ₹ 1128.2 crore as hospitals in India de-grew 2.4% QoQ followed by Cayman Islands, which de-grew 2.2% QoQ
    • EBITDA grew 4.4% QoQ to ₹ 254.4 crore. EBITDA margins grew 121 bps QoQ to 22.6%
    • Adjusted PAT declined 8.9% QoQ to ₹ 153.8 crore

Click here for full recommendation

Research view on more stocks

Healthcare Facilities company Narayana Hrudayalaya announced Q3FY24 results:

Financial Performance:
- Consolidated operating revenue for Q3FY24: Rs 12,036 million, a YoY growth of 6.7%.
- Consolidated EBITDA for Q3FY24: Rs 2,968 million, an 11.6% increase YoY with a margin of 24.7%.
- Consolidated PAT for Q3FY24: Rs 1,881 million, a 22.3% rise YoY with a PAT margin of 15.6%.
- India Operating Revenue for Q3FY24: Rs 9,590 million, up by 5.4% YoY.
- Cayman Operating Revenue for Q3FY24: Rs 2,576 million, an increase of 11.5% YoY.

Operational Highlights:
- Total Borrowings less Cash, Bank Balance, and Current Investments: Rs 251 million showcasing a net debt to equity ratio of (0.01).
- SRCC Mumbai treated a high-risk pediatric case successfully with a novel therapy.
- Mazumdar Shaw Medical Centre (MSMC) in Bengaluru introduced new services and accomplished notable medical procedures, handling 27 Solid Organ Transplants, 44 BMTs, 91 Robotic Procedures, and two rare renal transplants among others.

Commenting on the performance, Dr. Emmanuel Rupert, Managing Director and Group CEO, Narayana Hrudayalaya, said “After a strong second quarter, the third quarter of the fiscal year delivered a steady performance across our business units with a healthy YoY growth. The QoQ growth was impacted on account of festivals-related holidays in the current quarter. HCCI continues to contribute significantly to the overall performance and the new initiatives continue to see good traction. The new entity NHIC has delivered strong growth this quarter led by increased collections and steady inflow of patient transactions, remaining on track as per the plan.”

Result PDF

View Other Company Results

Narayana Hrudayalaya Ltd shares SWOT Analysis

Strengths (11)

  • Company with high TTM EPS Growth
  • Strong Annual EPS Growth
  • Effectively using its capital to generate profit - RoCE improving in last 2 years

Weakness (2)

  • MFs decreased their shareholding last quarter
  • Declining Net Cash Flow : Companies not able to generate net cash

Opportunity (0)

Data not found

Threats (3)

  • Companies with growing costs YoY for long term projects
  • Increasing Trend in Non-Core Income
  • RSI indicating price weakness

Resistance and support

R1 1,265.2
R2 1,287.9
R3 1,314.8
Pivot

1,238.27

S1 1,215.5
S2 1,188.6
S3 1,165.9
EMA SMA
1,275.3
1,276.2
1,244.0
1,155.5
1,270.6
1,301.5
1,264.4
1,155.2
Delivery and volume
CLIENT NAME DEAL TYPE ACTION DATE AVG. PRICE QUANTITY EXCHANGE
ISHARES CORE MSCI EMERGING MARKETS ETF Block Purchase 2022-10-17 729.7 176557 BSE
ISHARES MSCI INDIA SMALL-CAP ETF Block Purchase 2022-10-17 729.7 24703 BSE
ISHARES CORE EMERGING MARKETS MAURITIUS CO Block Sell 2022-10-17 729.7 176557 BSE
Name Category Shares
SHAKUNTALA SHETTY PROMOTER 30.38%
DEVI PRASAD SHETTY PROMOTER 11.66%
AMEYA SHETTY PROMOTER 5%
ANESH SHETTY PROMOTER 5%
VARUN SHETTY PROMOTER 5%
VIREN PRASAD SHETTY PROMOTER 5%
Narayana Health Academy Private Limited PROMOTER 1.81%

OUR RESEARCH VIEW

Investment recommendation
Steady quarter amid seasonality; focus on new capex
Call Date
11 Feb 2023
Entry Price 717.00
Target Price 870.00
Duration
12-18 Month

FINANCIALS

Sales
Operating Profit
Profit after Tax
Equity
Reserves and Surplus
Debt
Sales
Operating Profit
Profit after Tax
PE
Debt/Equity
P BV

Narayana Hrudayalaya Ltd Stocks COMPARISON

Financials( in Cr) Narayana Hrudayalaya Ltd Apollo Hospitals Enterprise Ltd Max Healthcare Institute Ltd Global Health Ltd Fortis Healthcare Ltd
Price 1,242.45 6,169.55 772.85 1,403.70 430.20
% Change 0.32 1.57 -0.67 2.24 -1.34
Mcap Cr 25,390.83 88,708.87 75,107.57 37,679.10 32,478.29
Revenue TTM Cr 4,524.77 16,612.50 4,831.37 2,694.25 6,537.06
Net Profit TTM Cr 606.57 887.50 1,103.51 326.08 632.98
PE TTM 32.88 112.57 70.95 83.33 60.74
1 Year Return 63.49 42.20 66.60 185.62 62.52
ROCE 29.27 14.16 13.85 16.49 7.51
ROE 33.51 15.04 16.12 16.13 6.79
INSIDER & INSTITUTIONAL ACTIVITY

Equity Capital: 2,132.67 Cr FV: 10.00

Period MF Net Purchase / (sold) FII Net
LAST 1M 24,289.49 -9,580.22
LAST 3M 82,644.28 34,986.47
LAST 6M 142,142.07 66,572.41
LAST 12M 216,755.16 194,314.28

Narayana Hrudayalaya Ltd Information

Stock PE (TTM)
32.88
Promoter Holding
63.85%
Book Value
122.4168
ROCE
29.27%
ROE
33.51%
Description
  • Narayana Hrudayalaya runs a chain of multi-speciality hospitals located across India. The company also operates primary care facilities, heart centres, and other healthcare facilities. The company has its headquarters in Bengaluru. Narayana Health was started by Dr Devi Shetty in 2000. As on 19 December 2022,  the company employs more than 11,000 professionals a year.

    On 19 December 2022, the market capitalisation of the company was Rs 15,434.35 crore. It reported consolidated sales of Rs 746.55 crore at the end of September 2022. The company is listed on the Bombay Stock Exchange with the code 539551 and the National Stock Exchange with the code NH.

    The promoters of Narayana Health currently hold approximately 63.85% of the company. The foreign institutional investors’ investment in the company amounts to 14.16%. Various mutual funds hold around 13.43% of the company. The total public stake in the company is approximately 8.3%. The stake of the public has grown steadily over the past year (Since September 2021).

    Dr Devi Prasad Shetty is the chairman of the company and a whole-time director, and Emmanuel Rupert is the CEO and managing director. Viren Prasad Shetty, Kiran Mazumdar Shaw, Arun Seth, Dinesh Krishnaswamy, and TS Bresenham are the other directors of the company. Deloitte, Haskins, & Sells LLP are the auditors of Narayana Health. As of December 2022, the company had around 20.4 crore shares outstanding.

    On 19 December 2022, Narayana Health’s share price on NSE was Rs 754.2 and Rs 753.3 on BSE. The share price touched a 52-week high of Rs 810.5 and a 52-week low of Rs 545.1. Its three-month return to investors was 8.64%, while its one-year return was 32.54%. The company’s total operating income grew 12.3% quarter-on-quarter during the fourth quarter of FY22.

    As of November 2022, Axis Small Cap Direct-G has invested Rs 501.1 crore in the company. Other prominent mutual funds with investments in Naryana include SBI Small Cap Direct-G, with an investment of Rs 266.8 crore, and Nippon India Pharma Direct-G, with an investment of Rs 221.4 crore in the company.

    Some of Narayana's peers include Max Healthcare, Fortis Healthcare, and Krishna Institute of Medicine.

    Disclaimer: ICICI Securities Ltd. (I-Sec). Registered office of I-Sec is at ICICI Securities Ltd. - ICICI Venture House, Appasaheb Marathe Marg, Prabhadevi, Mumbai - 400 025, India, Tel No : 022 - 6807 7100. I-Sec is a Member of National Stock Exchange of India Ltd (Member Code: 07730), BSE Ltd (Member Code: 103) and Member of Multi Commodity Exchange of India Ltd.(Member Code: 56250) and having SEBI registration no. INZ000183631. Name of the Compliance officer (broking): Ms. Mamta Shetty, Contact number: 022-40701022, E-mail address: complianceofficer@icicisecurities.com. Investments in securities market are subject to market risks, read all the related documents carefully before investing. The contents herein above shall not be considered as an invitation or persuasion to trade or invest. I-Sec and affiliates accept no liabilities for any loss or damage of any kind arising out of any actions taken in reliance thereon. Such representations are not indicative of future results. The securities quoted are exemplary and are not recommendatory. Investors should consult their financial advisers if in doubt about whether the product is suitable for them. The contents herein above are solely for informational purpose and may not be used or considered as an offer document or solicitation of offer to buy or sell or subscribe for securities or other financial instruments or any other product. Investors should consult their financial advisers whether the product is suitable for them before taking any decision. The contents herein mentioned are solely for informational and educational purpose.

Registered Address

No 258/A Bommasandra Indl Area, Anekal Taluq, Bengaluru, Karnataka, 560099

Tel : 91-80-71222802
Email : investorrelations:narayanahealth.org
Website : http://www.narayanahealth.org
Registrar

KFin Techologies Ltd

AGM Date (Month) : Aug
Face Value Equity Shares : 10
Market Lot Equity Shares : 1
BSE Code : 539551
NSE Code : NH
Book Closure Date (Month) :
BSE Group : A
ISIN : INE410P01011

FAQ’s on Narayana Hrudayalaya Ltd Shares

You can buy Narayana Hrudayalaya Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Narayana Hrudayalaya Ltd Share.

Company share prices and volatile and keep changing according to the market conditions. As of Apr 19, 2024 03:54 PM the closing price of Narayana Hrudayalaya Ltd was ₹ 1,242.45.

Market capitalization or market cap is determined by multiplying the current market price of a company’s shares with the total number of shares outstanding. As of Apr 19, 2024 03:54 PM, the market cap of Narayana Hrudayalaya Ltd stood at ₹ 25,390.83.

The latest PE ratio of Narayana Hrudayalaya Ltd as of Apr 19, 2024 03:54 PM is 32.88

The latest PB ratio of Narayana Hrudayalaya Ltd as of Apr 19, 2024 03:54 PM is 0.10

The 52-week high of Narayana Hrudayalaya Ltd share price is ₹ 1,444.90 while the 52-week low is ₹ 748.90

According to analyst recommendations, Narayana Hrudayalaya Ltd Share has a “Buy” rating for the long term.

Download Our

Download App
market app